Last edition
News about Global Pharma
Bayer Launches Bayer Co.Lab AdVenture Platform in China
Bayer launches Co.Lab AdVenture to connect biotech startups with global VCs, accelerating early-stage innovation through its lifesciences incubator network.
Global Pharma | 11/09/2025 | By Dineshwori | 230
GBI Biomanufacturing has partnered with NanoRetinal to advance development and manufacturing of NAR-001, a novel nanoparticle therapy for Inherited Retinal Diseases.
Global Pharma | 10/09/2025 | By Mrinmoy Dey | 166
Wheeler Bio has partnered with Pharmefex Consulting to strengthen its ModularCMC platform by integrating regulatory and CMC expertise for accelerated IND submissions.
Global Pharma | 10/09/2025 | By Mrinmoy Dey | 139
AstraZeneca Rolls Out Anti-Complement Therapy for aHUS and PNH
AstraZeneca India launches Eculizumab (300 mg, 10 mg/ml), the first approved anti-complement therapy in India for the treatment of atypical Haemolytic Uremic Syndrome (aHUS) and Paroxysmal Nocturnal Hemoglobinuria (PNH), following CDSCO approval in January 2025 for import, sale and distribution.
Global Pharma | 09/09/2025 | By Dineshwori | 207
Made Scientific, Hemogenyx Partner to Advance CAR-T Cell Therapy for AML
Made Scientific and Hemogenyx Pharmaceuticals have announced a technology transfer and manufacturing partnership to advance HG-CT-1, an autologous CAR-T cell therapy for acute myeloid leukaemia (AML).
Global Pharma | 09/09/2025 | By Mrinmoy Dey | 156
Novartis to Acquire Tourmaline Bio for USD 48 per share
Novartis to acquire Tourmaline Bio in a USD 1.4 billion deal, gaining rights to pacibekitug—an anti-IL-6 antibody with potential in cardiovascular disease; transaction expected to close in Q4 2025.
Global Pharma | 09/09/2025 | By Dineshwori | 274
Ichnos Glenmark Innovation Secures USD 700M Upfront in AbbVie Licensing Deal for ISB 2001
Ichnos Glenmark Innovation (IGI) has received an upfront payment of USD 700 million from AbbVie under the terms of their recently announced global licensing agreement for IGI’s lead investigational asset, ISB 2001.
Global Pharma | 09/09/2025 | By Dineshwori | 362
Indegene Expands India Footprint with New Centre in Pune
Indegene, a digital-first life sciences commercialisation company, has expanded its India footprint with the launch of a new centre in Pune.
Global Pharma | 08/09/2025 | By Mrinmoy Dey | 213
Servier to Acquire KER-0193 from Kaerus Bioscience in Deal Worth Up to USD 450 Million
Servier has signed a definitive agreement to acquire KER-0193 from Kaerus Bioscience, a potential first-in-disease treatment for Fragile X syndrome, the most common genetic cause of autism spectrum disorder.
Global Pharma | 08/09/2025 | By Mrinmoy Dey | 271
Ronovo Surgical Closes Series D Financing
Ronovo Surgical secures USD 67 million in Series D funding led by JJDC, raising over USD 100 million in 2025 to advance minimally invasive surgery.
Global Pharma | 06/09/2025 | By Dineshwori | 230
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy